Lose the weight, keep your life

Complete a short online visit with your health history, goals and measurements. A licensed U.S. provider reviews it, and if a GLP-1 is appropriate, your prescription is sent to a partner pharmacy and shipped to your door — usually within a few business days.

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GLP-1 and GIP receptors, which in clinical studies has been associated with greater average weight reduction. Your provider recommends one based on your history, tolerance and goals.

Published trials report average total body weight reductions in the range of roughly 15% for semaglutide and up to about 20% for tirzepatide over 68–72 weeks, combined with diet and activity changes. Individual results vary and are not guaranteed.

FaroRx compounded GLP-1 plans start at $159 per month, including the medication, provider oversight, supplies and free shipping. There are no membership or consultation fees on top of the plan price.

Compounded medications are typically paid out of pocket and are not billed to insurance. Many patients use HSA or FSA funds. We provide receipts on request.

No. Brand products such as Ozempic and Wegovy are FDA-approved medications made by their manufacturers. Compounded semaglutide is prepared by a licensed U.S. compounding pharmacy and is not an FDA-approved product. Compounded medications are prepared by a licensed U.S. compounding pharmacy and are not FDA-approved products. Treatment is prescribed only if a licensed provider determines it is appropriate for you.

Nausea, constipation, diarrhea, reflux, fatigue and injection-site irritation are the most commonly reported. They are usually mild and improve as your body adjusts to each dose step. Report anything severe or persistent to your care team right away.

Most patients notice reduced appetite and smaller portions within the first one to two weeks. Measurable weight change usually appears between weeks 4 and 12 as your dose is titrated upward.

Yes — GLP-1 treatment is a small weekly subcutaneous injection you give yourself, typically in the abdomen, thigh or upper arm. Your kit includes needles, alcohol swabs and step-by-step instructions, and your care team can walk you through the first dose.

Appetite usually returns and some weight regain is common after stopping. Many patients transition to a maintenance dose rather than stopping abruptly. Your provider will build a taper or maintenance plan with you.

Hair shedding reported on GLP-1s is usually telogen effluvium — a temporary response to rapid weight loss and lower calorie intake rather than a direct drug effect. Adequate protein, iron and a slower rate of loss help. FaroRx also offers hair treatments if shedding persists.

Providers generally consider a BMI of 30 or higher, or 27 and above with a weight-related condition such as high blood pressure, prediabetes or sleep apnea. Eligibility is a clinical decision made during your visit.

GLP-1 medications are not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, active pancreatitis, or who are pregnant or breastfeeding. Disclose your full history during the intake.

FaroRx works with providers licensed in all 50 U.S. states and the District of Columbia. Availability of specific formulations can vary by state pharmacy regulations.

Medication ships cold-chain in discreet, unbranded packaging with tracking, at no additional cost. Most orders arrive within 2–5 business days of provider approval.

Some patients add lipotropic MIC + B12 support alongside a GLP-1. Combining treatments is only done when your provider reviews both and confirms it is appropriate for you.